Skip to main content
Clinical Trials/TCTR20230405001
TCTR20230405001
Not yet recruiting
Phase 4

The effectiveness of peripheral magnetic stimulation combined with conventional therapy in moderate degree carpal tunnel syndrome : a randomized, assessor blinded, controlled trial

/A0 sites60 target enrollmentApril 5, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Moderate degree of carpal tunnel syndrome
Sponsor
/A
Enrollment
60
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 5, 2023
End Date
December 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • 1\.Age 20\-80 years
  • 2\.Moderate to severe degree CTS by electrodiagnostic study
  • 3\.Willing to participate in the study

Exclusion Criteria

  • 1\.Electrodiagnosis reveals : Absent SNAP, absent CMAP or CMAP amplitude \<5 mV
  • 2\.History of treatment of carpal tunnel syndrome by steroid injection \< 6 months, physical modalities within 1 month, using NSAIDs drug within 2 week, using wrist splint within 3 month or had already underwent carpal tunnel surgery
  • 3\.Contraindication for peripheral magnetic stimulation : Pregnancy, Active malignancy, Epilepsy, Pacemaker, Intracranial/spinal metal object, Cochlear implant, History of wrist fracture at affected side, DVT at affected arm
  • 4\.Diagnosed as cervical radiculopathy, polyneuropathy, inflammatory rheumatoid, diabetes neuropathy or poor controlled diabetes mellitus
  • 5\.Cannot tolerate the wrist splint
  • 6\.Severe perception and communication impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials